![]() |
|
|
Molecular Pharmacology, Vol 9, 297-303, Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics
1 McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706
Precancerous livers were induced in rats by feeding the animals a diet containing 0.05 % (w/w) of the hepatocarcinogenic azo dye-3'-methyl-4-dimethylaminoazobenzene for 3 weeks. The contribution of de novo gnd salvage pathways to the synthesis of DNA pyrimidines in precancerous liver in vivo was monitored by simultaneously measuring the incorporation of [6-14C]orotic acid into DNA cytosine and DNA thymine and of [methyl-3H]-thymidine into DNA thymine, respectively. The incorporation of these precursors into total liver DNA, the DNA of hepatic cell suspensions, and the DNA of different classes of hepatic nuclei was determined. In addition, the activities of deoxycytidine monophosphate deaminase (dCMP aminohydrolase, EC 3.5.4.12), thymidine kinase (ATP: thymidine 5'-phosphotransferase, EC 2.7.1.21) and thymidylate synthetase (EC 2.1.1b) were measured in hepatic cell suspensions and in whole homogenates prepared from precancerous liver. These studies emphasize that, with regard to several aspects of pyrimidine nucleotide metabolism, precancerous liver is composed of a heterogeneous population of cells. The use of thymidine incorporation as the sole measure of the rate of DNA synthesis is shown to be questionable, and it is suggested that simultaneous assessment of both de novo and salvage pathways for the synthesis of DNA precursors is required for an accurate estimate of the extent of DNA synthesis.
Note:
ACKNOWLEDGMENTS
The authors wish to thank Drs. J. A. and E. C.
Miller for providing the special diets used in these
studies, and Dr. C. Heidelberger for providing the
FUdR.
This article has been cited by other articles:
![]() |
D. A. Kooby, K. L. Zakian, S. N. Challa, C. Matei, H. Petrowsky, H.-H. Yoo, J. A. Koutcher, and Y. Fong Use of Phosphorous-31 Nuclear Magnetic Resonance Spectroscopy to Determine Safe Timing of Chemotherapy after Hepatic Resection Cancer Res., July 1, 2000; 60(14): 3800 - 3806. [Abstract] [Full Text] |
||||